戻る Agenda
Digital Risk Minimization Tools
Session Chair(s)
Michael Forstner, PhD, MPH, MSc
Managing Director, Head of Pharmacoepidemiology Practice
Mesa Laubela-Consulting, Switzerland
Risk minimization in patient safety still relies mostly on paper based communication with patients and HCPs. Truly digital approaches allow for more control, improved communication, faster responses and better evaluation, and thus improved safety.
Learning Objective : - Understand the potential for truly digital risk minimization approaches - Make use of digital tools for two-way communication with patients and health-care providers - Utilize data and meta-data generated with digital risk minimization tools to optimize benefit-risk profiles of medicines
Speaker(s)
Digital Risk Minimization and Signal Management
Israel Gutierrez, MD
TLR Therapeutics Inc, United States
Chief Medical Officer
Real World Evidence Strategy and Digital Risk Minimization
Maartje Smulders, MPH, MS, MSc
Astellas Pharma Europe BV, Netherlands
Senior Director Medical Affairs Epidemiology